Panel de control de cohortes

La misión del GP2 es comprender la arquitectura genética de la enfermedad de Parkinson (EP) mediante el genotipado de grupos de pacientes diversos y el estudio de formas de la EP de las cuales se sospecha que son monogénicas. Para apoyar esta misión, seguimos recopilando cohortes diversas de todo el mundo a través de la colaboración y compartiendo datos, procesos y resultados de manera abierta. Explore el siguiente panel de control, donde encontrará los logros alcanzados hasta la fecha, y vuelva a visitar esta página periódicamente, ya que actualizamos los datos trimestralmente.

Datos globales totales

0
Ubicaciones únicas
0
Cohortes
0
Muestras pendientes
0
Muestras completadas

Última actualización: 9 de septiembre del 2021 | Diseño original del equipo GP2 Hackathon 2021: Mary Makarious, Kajsa Brolin, Yeajin Song y Anastasia Illarionova

Showing 10 of 238 cohort studies.

To be updated - Hacettepe University

Hacettepe University | Ankara, Turkey
Number of Samples Completed and Expected
Case Samples
Case Samples

Pending
Non-PD Samples
Non-PD Samples

Pending
Total Samples
Total Samples

0 Completed out of 0 Expected

To be updated - Karolinska Institutet

Karolinska Institute | Stockholm, Sweden
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 650 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 30 Expected
Total Samples
Total Samples

0 Completed out of 680 Expected

To be updated - Research Center of Neurology

Research Center of Neurology | Moscow, Russia
Number of Samples Completed and Expected
Case Samples
Case Samples

Pending
Non-PD Samples
Non-PD Samples

Pending
Total Samples
Total Samples

0 Completed out of 0 Expected

To be updated - RSUP Manado, Sulawesi

Rumah Sakit Umum Pusat (RSUP) | Sulawesi, Indonesia
Number of Samples Completed and Expected
Case Samples
Case Samples

Pending
Non-PD Samples
Non-PD Samples

Pending
Total Samples
Total Samples

0 Completed out of 0 Expected

To be updated - University of Toronto

University of Toronto | Toronto, Canada
Number of Samples Completed and Expected
Case Samples
Case Samples

Pending
Non-PD Samples
Non-PD Samples

Pending
Total Samples
Total Samples

0 Completed out of 0 Expected

TONiC PD

Perron Institute for Neurological and Translational Science | Perth, Australia
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

43 Completed out of 500 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 400 Expected
Total Samples
Total Samples

43 Completed out of 900 Expected
Ancestry Breakdown for Samples Completed
Show

Trondheim Study

Norwegian University of Science and Technology | Trondheim, Norway
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

796 Completed out of 1,300 Expected
Non-PD Samples
Non-PD Samples

471 Completed out of 500 Expected
Total Samples
Total Samples

1,267 Completed out of 1,800 Expected
Ancestry Breakdown for Samples Completed
Show

Tuepac + TREND

Universität Tübingen | Tuebingen, Germany
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

2,489 Completed out of 2,900 Expected
Non-PD Samples
Non-PD Samples

1,053 Completed out of 1,200 Expected
Total Samples
Total Samples

3,542 Completed out of 4,100 Expected
Ancestry Breakdown for Samples Completed
Show

Tuepac + TREND - M

Universität Tübingen | Tuebingen, Germany
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

33 Completed out of 50 Expected
Non-PD Samples
Non-PD Samples

5 Completed out of 0 Expected
Total Samples
Total Samples

38 Completed out of 50 Expected
Ancestry Breakdown for Samples Completed
Show

UGCPD

Center for Neurodiagnostic Therapeutic Services, Metropolitan Medical Center | Manila, The Philippines
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 70 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 30 Expected
Total Samples
Total Samples

0 Completed out of 100 Expected

Solicitar conjunto de datos de AMP-PD

Una vez que el GP2 completa el genotipado de una cohorte, todos los datos se comparten en la plataforma segura AMP® PD. Regístrese para solicitar acceso a estos datos.

Aportar una cohorte

Si desea colaborar con el GP2, póngase en contacto con nosotros para aportar una cohorte o infórmese sobre cómo hacerse miembro.

Conozca los miembros del GP2 de todo el mundo

Explore las organizaciones miembro que hacen que nuestra investigación sea posible gracias a su colaboración y contribución de muestras y datos.